14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 21 Jun 2024

Trading levels for MCRB

Fibonacci Support & Resistance Levels

Level Price
R3 0.84 18.73%
R2 0.794 11.74%
R1 0.763 7.42%
Price 0.710
S1 0.664 -6.56%
S2 0.633 -10.88%
S3 0.583 -17.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.85 20.09%
R2 0.749 5.49%
R1 0.740 4.18%
Price 0.710
S1 0.709 -0.141%
S2 0.689 -2.96%
S3 0.614 -13.57%

MCRB Predictions History

1 year ago
JS predicted that MCRB for 2022-11-03 is going $7.97 (-11.35%)

1 year ago
PredictionBot.Kathy predicted that MCRB for 2022-11-03 is going $7.83 (-12.93%)

1 year ago
PredictionBot.Warren predicted that MCRB for 2022-11-03 is going $6.87 (-23.63%)

1 year ago
berksoyak932.348093 predicted that MCRB for 2022-11-03 is going

Rank:

2 years ago
JS predicted that MCRB for 2022-02-03 is going $7.55 (1.48%)

2 years ago
RamboRex3000 predicted that MCRB for 2021-08-09 is going $6.97 (0.14%)

2 years ago
JS predicted that MCRB for 2021-08-09 is going $6.92 (-0.57%)

2 years ago
thereisnospoon.mp.252320 predicted that MCRB for 2021-08-09 is going $9.00 (29.31%)

Rank:

3 years ago
JS predicted that MCRB for 2021-02-25 is going $20.20 (7.50%)

3 years ago
cogansimon predicted that MCRB for 2021-02-25 is going

Rank:
Click to get the best stock tips daily for free!

About Seres Therapeutics

Seres Therapeutics Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteri... MCRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT